These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8568018)

  • 21. Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
    Gidal BE; Spencer NW; Maly MM; Pitterle ME
    Epilepsia; 1996 Apr; 37(4):381-5. PubMed ID: 8603645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free and total serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in infancy and childhood.
    Riva R; Contin M; Albani F; Perucca E; Lamontanara G; Baruzzi A
    Epilepsia; 1985; 26(4):320-2. PubMed ID: 4006891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults.
    Lanchote VL; Bonato PS; Campos GM; Rodrigues I
    Ther Drug Monit; 1995 Feb; 17(1):47-52. PubMed ID: 7725376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children.
    Tran A; Vauzelle-Kervroedan F; Rey E; Pous G; d'Athis P; Chiron C; Dulac O; Renard F; Olive G
    Eur J Clin Pharmacol; 1996; 50(6):497-500. PubMed ID: 8858278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
    Brodie MJ; Fakhoury T; McDonough B; Colson AO; Stockis A; Elmoufti S; Whitesides J
    Epilepsy Res; 2018 Sep; 145():55-62. PubMed ID: 29908435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
    Kong ST; Lim SH; Chan E; Ho PC
    J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
    Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing serum levels of carbamazepine and carbamazepine-10,11-epoxide in children.
    Altafullah I; Talwar D; Loewenson R; Olson K; Lockman LA
    Epilepsy Res; 1989; 4(1):72-80. PubMed ID: 2753022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine and carbamazepine-epoxide serum protein binding in newborn infants.
    Groce JB; Casto DT; Gal P
    Ther Drug Monit; 1985; 7(3):274-6. PubMed ID: 4049463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.
    Chbili C; Hassine A; Ben Amor S; Nouira M; Ben Ammou S; Saguem S
    Rev Neurol (Paris); 2016; 172(4-5):313-7. PubMed ID: 27062293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence.
    Korinthenberg R; Haug C; Hannak D
    Neuropediatrics; 1994 Aug; 25(4):214-6. PubMed ID: 7824094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography.
    Yoshida T; Imai K; Motohashi S; Hamano S; Sato M
    J Pharm Biomed Anal; 2006 Jun; 41(4):1386-90. PubMed ID: 16597494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of interaction of gabapentin with carbamazepine or valproate.
    Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR
    Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
    Macphee GJ; Butler E; Brodie MJ
    Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
    MacKichan JJ; Duffner PK; Cohen ME
    Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carbamazepine presence in plasma lipoproteins].
    Szymańska-Shawkat E; Dyderski S; Dobrowolska E; Steinborn B
    Neurol Neurochir Pol; 2000; 34 Suppl 1():61-6. PubMed ID: 10768146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.